Papa Giovanni XXIII Hospital clinical trials
Papa Giovanni XXIII Hospital is the lead sponsor of 5 current clinical trials in our Italy register. 3 are recruiting patients now. All registered phases are Observational. The most-studied condition is Coronary Artery Disease (CAD).
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Papa Giovanni XXIII Hospital
5 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Percutaneous Intercostal Cryoneuromodulation Onset Timing.
NCT07081620 · ClinicalTrials.gov ↗ · Cryotherapy Effect, Pectus Excavatum
|
Observational | Recruiting | 2025-06 | Italy |
|
Camera-based Endoscopy Allows Spontaneous Breathing Diagnostic Management in Neonates With Tracheoesophageal Fistula
NCT07687628 · ClinicalTrials.gov ↗ · Tracheoesophageal Fistula, Esophageal Atresia With Tracheo-esophageal Fistula
|
Observational | Recruiting | 2024-10 | Italy |
|
Long Term Safety of Preoperative Percutaneous Intercostal Cryoneurolysis
NCT07657845 · ClinicalTrials.gov ↗ · Cryo Analgesia, Pectus Surgery
|
Observational | Recruiting | 2025-02 | Italy |
|
Overviewing Real-World Outcomes to Boost Interventional Management of CAlcified Coronary Lesions: the OROBICA Registry.
NCT07566403 · ClinicalTrials.gov ↗ · Coronary Artery Disease (CAD), Calcific Coronary Arteriosclerosis, Intravascular Lithotripsy; Rotational Atherectomy; OFDI
|
Observational | Not yet open | 2026-06 | Italy |
|
Percutaneous Portal Vein Recanalization for Refractory Portal Hypertension in Children With Non-Cirrhotic Extrahepatic Portal Vein Obstruction
NCT07873021 · ClinicalTrials.gov ↗ · Hypertension, Portal, Interventional Radiology, Percutaneous Portal Vein Recanalization (PVR)
|
Observational | Active, closed | 2022-01 | Italy |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Conditions in Papa Giovanni XXIII Hospital trials
14 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Italy | 5 | 3 |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Coronary Artery Disease (CAD)
Sponsors with the most current trials registered for this condition.
Questions about Papa Giovanni XXIII Hospital trials
How many clinical trials does Papa Giovanni XXIII Hospital sponsor?
Papa Giovanni XXIII Hospital is the lead sponsor of 5 current trials on ClinicalTrials.gov in our Italy register, as of the registry sync on 14 November 2026. Completed and withdrawn studies are not counted.
Are Papa Giovanni XXIII Hospital trials recruiting?
Yes. 3 of its 5 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 14 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.